There are currently 3.8 million women with a history of breast cancer living in the United States. Since 1989 the death rate has plunged 40%. According to the American Cancer… Read More

Ductal carcinoma in situ (DCIS) is breast cancer, which does not leave the milk duct and cannot spread to other parts of the body (metastasize). Before the mid1980s, it was… Read More

A post on this website several weeks ago discussed the impact of examining breast cancer genes and how it has impacted treatment. It is important to remember that we are… Read More

Between 1-2 women out of every 10 who developed breast cancer, have what is considered locally advanced disease. Locally advanced disease is generally considered tumors greater than 2 cm in… Read More

For a tumor to grow or progress, the cancer cell must evade the immune system. In the past, it was thought that only melanoma and kidney cancers would respond to… Read More

We have long known that the body puts out special hormones or chemicals in response to stress and inflammation. The most important of these are epinephrine (Adrenaline™), cortisone, and hormones… Read More

In this Prophylactic Mastectomy and Breast Reconstruction video series, watch as surgeons at the Center for Restorative Breast Surgery explain how prophylactic mastectomy can reduce the risk of breast cancer by about 90%. To restore a sense of wholeness, many women decide to have breast reconstruction immediately after prophylactic mastectomy surgery.… Read More

Until several years ago, a majority of women who developed invasive breast cancer required chemotherapy with or without hormonal therapy as part of their treatment. In the early 2000s, we… Read More

BRCA1 and BRCA2 are far and away the most commonly inherited mutations that predispose women to breast and ovarian cancer. However, since the relatively recent use of panel testing, multiple genes have been discovered that can also predispose women to breast, ovarian, and other cancers.… Read More